SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $618,000 | -5.1% | 55,139 | -6.9% | 0.00% | – |
| Q2 2017 | $651,000 | -63.4% | 59,221 | -67.4% | 0.00% | -100.0% |
| Q1 2017 | $1,779,000 | +13.2% | 181,492 | +24.8% | 0.00% | 0.0% |
| Q4 2016 | $1,571,000 | +662.6% | 145,458 | +625.4% | 0.00% | – |
| Q3 2016 | $206,000 | -22.3% | 20,052 | -1.3% | 0.00% | – |
| Q2 2016 | $265,000 | 0.0% | 20,320 | -15.7% | 0.00% | – |
| Q1 2016 | $265,000 | +25.6% | 24,115 | +4.9% | 0.00% | – |
| Q4 2015 | $211,000 | -48.5% | 22,984 | -61.1% | 0.00% | – |
| Q3 2015 | $410,000 | -46.5% | 59,115 | -24.3% | 0.00% | – |
| Q2 2015 | $767,000 | -25.1% | 78,117 | -32.5% | 0.00% | – |
| Q1 2015 | $1,024,000 | +157.9% | 115,658 | +154.9% | 0.00% | – |
| Q4 2014 | $397,000 | +26.8% | 45,382 | +0.0% | 0.00% | – |
| Q3 2014 | $313,000 | +19.0% | 45,364 | -9.4% | 0.00% | – |
| Q2 2014 | $263,000 | +28.3% | 50,090 | +11.2% | 0.00% | – |
| Q1 2014 | $205,000 | -9.7% | 45,044 | 0.0% | 0.00% | – |
| Q4 2013 | $227,000 | -36.2% | 45,044 | -35.9% | 0.00% | – |
| Q3 2013 | $356,000 | -26.0% | 70,322 | -27.5% | 0.00% | – |
| Q2 2013 | $481,000 | – | 96,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|